SCHEMBL22145142

SCHEMBL22145142

CCOC(=O)Nc1cc(OCc2ccccc2)c2ccccc2c1-c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
HPGD P15428 1/20 0.48
BRD4 O60885 2/20 0.45
PTGER1 P34995 1/20 0.45
POLB P06746 2/20 0.44
KDM4E B2RXH2 1/20 0.44
GLA P06280 1/20 0.44
PTPN1 P18031 1/20 0.44
MGLL Q99685 1/20 0.43
KDR P35968 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
PPIA P62937 1/20 0.43
TACR3 P29371 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22149090 0.80 MGLL (0.47) NPC1RAB9AHPGDPTPN1MGLL
SCHEMBL22145265 0.78 MAPT (0.51) ALDH1A1KDM4EKDRCYP1A2CYP2C9
SCHEMBL22145236 0.76 LMNA (0.48) ALDH1A1HPGDBRD4KDM4EGAA
SCHEMBL11670391 0.75 CREBBP (0.57) NPC1RAB9AHPGDBRD4PTGER1
SCHEMBL15763605 0.75 FOLH1 (0.51) ALDH1A1PTGER1POLBKDM4E
SCHEMBL11879436 0.74 RAB9A (0.61) ALDH1A1NPC1RAB9AHPGDBRD4
SCHEMBL15014407 0.74 CYP2C9 (0.48) NPC1RAB9ABRD4PTGER1CYP2C9
SCHEMBL17736786 0.74 ALDH1A1 (0.49) ALDH1A1NPC1RAB9APOLBMEN1
SCHEMBL9721922 0.73 ALDH1A1 (0.61) ALDH1A1NPC1RAB9AHPGDPOLB
SCHEMBL2070523 0.73 CYP19A1 (0.76) ALDH1A1CYP1A2CYP2C9CYP2C19MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3898636-B9 INDOLONAPHTHOPYRANS TRANSITIONS OPTICAL LTD (IE) 2023-11-08 EP disclosed
EP-3898636-B1 INDOLONAPHTHOPYRANS TRANSITIONS OPTICAL LTD (IE) 2023-08-30 EP disclosed
US-20220056039-A1 Indolonaphthopyrans TRANSITIONS OPTICAL, LTD. (IE) 2022-02-24 US disclosed
WO-2020126032-A1 INDOLONAPHTHOPYRANS TRANSITIONS OPTICAL, LTD. (IE) 2020-06-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220056039-A1 Indolonaphthopyrans TPH1, TPH2, IDO1 ALDH1A1 230/4885NPC1 4095/4885RAB9A 3592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.